Definitive Contract 75N91020C00055
Award Date 9/16/20
Potential Completion Date 5/31/22
Potential Value $452K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21211, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Malcova Inc., a for-profit manufacturer of goods, was awarded a $1,998,128.00 firm fixed price contract by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), under the Small Business Innovation Research (SBIR) Program Phase II. The 27-month contract, set aside for small businesses, focuses on the development of patient-derived anthropomorphic phantoms for automated objective assessment of breast imaging systems. As the prime contractor, Malcova Inc. will...
- This FY20 Phase I SBIR contract, valued at $454,778, was awarded to Calibermri, Inc. by the National Institutes of Health National Cancer Institute to develop a quantitative biomimetic MRI breast tissue and tumor phantom toward a comprehensive phantom solution for breast cancer diagnostics and treatment monitoring. The contract is a firm fixed price vehicle with a performance period from September 2020 through October 2021 in Boulder, Colorado. The award is responsive to the National...
- This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
- This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Matrisome Bio, Inc. for the development of "Novel Theranostic Radioligands Targeting Disease-Specific Extracellular Matrix Components Specific to Tumor and Metastatic Lesions in Patients Suffering from Hereditary Breast and Ovarian Cancer (HBOC)." The contract has a firm fixed price of $354,456.00 and a completion date of September 14, 2026. As this...
- This $397,148 firm fixed price contract was awarded by the National Institutes of Health National Cancer Institute to Computerized Imaging Reference Systems, Inc. Medical Division for research under TOPIC 421: MULTI-COMPARTMENT PHANTOM MATERIALS FOR QUANTITATIVE, MULTI-PARAMETIC MRI OF THE PROSTATE. The work will be performed in Norfolk, Virginia over one year in response to the National Institutes of Health and Centers for Disease Control and Prevention Small Business Innovation Research...
- This $2,399,183 firm-fixed-price SBIR Phase I contract was awarded by the National Cancer Institute (NCI) to Radiologics, Inc., a small business, to conduct research and development on cancer imaging tools and image de-identification software. The contract is part of the NCI's SBIR program, which aims to stimulate technological innovation and increase private sector commercialization of innovations derived from federal R&D. The contract has a period of performance through January 2024 and is...
- <p>This is a $299,813 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Hylapharm LLC, a self-certified small disadvantaged business, under the SBIR Program Phase I. The contract is for the development of "Targeted Nanoparticle Treatment for Breast Cancer Stem Cells." This contract has a Total Small Business set-aside designation. The contract has an ultimate completion date of September 17, 2016.</p>
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Radiologics, Inc., a for-profit organization. The contract, valued at $225,000.00, is for the development of FDA-compliant imaging informatics for cancer research under SBIR Topic 365. As a SBIR Phase I award, this contract is set aside for small businesses. The contract has a firm fixed price pricing type and was awarded on September 18, 2017, with...
- This definitive firm fixed price contract from the Department of Health and Human Services National Institutes of Health National Cancer Institute, with a total small business set aside, is for $299,726.89 to Imago Systems Inc. for the development of a novel diagnostic imaging modality for monitoring tumor responses to a hyperthermia immunotherapy as part of the National Cancer Institute's Moonshot initiative. The award stems from Topic 375 of the NIH/CDC SBIR Contract Solicitation PHS 2018-1,...